BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30909527)

  • 21. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
    Pasiana AD; Idrus HH; Purnamasari I
    Drug Des Devel Ther; 2024; 18():1023-1024. PubMed ID: 38585253
    [No Abstract]   [Full Text] [Related]  

  • 22. The flavonoid quercetin reverses pulmonary hypertension in rats.
    Morales-Cano D; Menendez C; Moreno E; Moral-Sanz J; Barreira B; Galindo P; Pandolfi R; Jimenez R; Moreno L; Cogolludo A; Duarte J; Perez-Vizcaino F
    PLoS One; 2014; 9(12):e114492. PubMed ID: 25460361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of fatty acid synthase is protective in pulmonary hypertension.
    Singh N; Manhas A; Kaur G; Jagavelu K; Hanif K
    Br J Pharmacol; 2016 Jun; 173(12):2030-45. PubMed ID: 27061087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Efficacy of Curcumin and Caffeic Acid Phenethyl Ester in Breast Cancer by Preclinical Studies.
    Verma SS; Avadhesh ; Srivastava A; Shekher A; Dhasmana A; Narula AS; Gupta SC
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38523543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell and Spatial Transcriptomics Identified Fatty Acid-binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.
    Liu B; Yi D; Li S; Ramirez K; Xia X; Cao Y; Zhao H; Tripathi A; Qiu S; Kala M; Rafikov R; Gu H; de Jesus Perez V; Lemay SE; Glembotski CC; Knox KS; Bonnet S; Kalinichenko VV; Zhao YY; Fallon MB; Boucherat O; Dai Z
    bioRxiv; 2024 Apr; ():. PubMed ID: 38370670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.
    Tuder RM; Davis LA; Graham BB
    Am J Respir Crit Care Med; 2012 Feb; 185(3):260-6. PubMed ID: 22077069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computational growth and remodeling framework for adaptive and maladaptive pulmonary arterial hemodynamics.
    Szafron JM; Yang W; Feinstein JA; Rabinovitch M; Marsden AL
    Biomech Model Mechanobiol; 2023 Dec; 22(6):1935-1951. PubMed ID: 37658985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells.
    Cavaliere V; Papademetrio DL; Lorenzetti M; Valva P; Preciado MV; Gargallo P; Larripa I; Monreal MB; Pardo ML; Hajos SE; Blanco GA; Alvarez EM
    Transl Oncol; 2009 Mar; 2(1):46-58. PubMed ID: 19252751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Jin H; Jiao Y; Guo L; Ma Y; Zhao R; Li X; Shen L; Zhou Z; Kim SC; Liu J
    Int J Mol Med; 2021 Feb; 47(2):595-606. PubMed ID: 33416126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ.
    Zehendner CM; Valasarajan C; Werner A; Boeckel JN; Bischoff FC; John D; Weirick T; Glaser SF; Rossbach O; Jaé N; Demolli S; Khassafi F; Yuan K; de Jesus Perez VA; Michalik KM; Chen W; Seeger W; Guenther A; Wasnick RM; Uchida S; Zeiher AM; Dimmeler S; Pullamsetti SS
    Am J Respir Crit Care Med; 2020 Nov; 202(10):1445-1457. PubMed ID: 32634060
    [No Abstract]   [Full Text] [Related]  

  • 31. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.
    Lu Y; Gao L; Zhang W; Zeng Y; Hu J; Song K
    Ren Fail; 2024 Dec; 46(1):2350235. PubMed ID: 38721924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise capacity-hemodynamics mismatch in elderly patients with pulmonary hypertension: A nationwide multicenter study from Taiwan Society of Cardiology Pulmonary Hypertension Registry (TAIPANS).
    Chen CY; Mei-Tzu W; Sung SH; Wu YJ; Hsu CH; Ho WJ; Lin YH; Liu WS; Liu JC; Kao YT; Wu WS; Wu CH; Lei MH; Chen YW; Chen-Yu C; Chiu YW; Dai ZK; Lin TH; Lin L; Chung CC; Chung CM; Huang SH; Cheng CC; Wu YW; Chao TH; Hwang JJ; Jia-Yin Hou C; Huang WC
    Heliyon; 2024 Mar; 10(6):e27537. PubMed ID: 38515682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.
    Wan JJ; Yi J; Wang FY; Zhang C; Dai AG
    Int J Med Sci; 2024; 21(1):45-60. PubMed ID: 38164358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.
    Wang MT; Chi PL; Cheng CC; Huang WC; Chen LW
    Cardiol J; 2024; 31(2):285-299. PubMed ID: 37772357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities.
    Pérez R; Burgos V; Marín V; Camins A; Olloquequi J; González-Chavarría I; Ulrich H; Wyneke U; Luarte A; Ortiz L; Paz C
    Antioxidants (Basel); 2023 Jul; 12(8):. PubMed ID: 37627495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension.
    Zeidan EM; Hossain MA; El-Daly M; Abourehab MAS; Khalifa MMA; Taye A
    J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH
    Fan F; Zou Y; Wang Y; Zhang P; Wang X; Dart AM; Zou Y
    Front Pharmacol; 2021; 12():768513. PubMed ID: 35002707
    [No Abstract]   [Full Text] [Related]  

  • 38. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
    Chi PL; Cheng CC; Hung CC; Wang MT; Liu HY; Ke MW; Shen MC; Lin KC; Kuo SH; Hsieh PP; Wann SR; Huang WC
    Int J Biol Sci; 2022; 18(1):331-348. PubMed ID: 34975336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: Implications in drug development.
    Hu XQ; Zhang L
    Drug Discov Today; 2021 Nov; 26(11):2754-2773. PubMed ID: 34302972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.
    Wu K; Tang H; Lin R; Carr SG; Wang Z; Babicheva A; Ayon RJ; Jain PP; Xiong M; Rodriguez M; Rahimi S; Balistrieri F; Rahimi S; Valdez-Jasso D; Simonson TS; Desai AA; Garcia JGN; Shyy JY; Thistlethwaite PA; Wang J; Makino A; Yuan JX
    Pulm Circ; 2020; 10(3):2045894020948470. PubMed ID: 33294172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.